Total number of projects: 6
As coordinator: 1
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0.2*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2014 | 0 | 5.993.000 | 391.758 | 1 | ||
2013 | 11.869.000 | 23.993.051 | 787.238 | 1 | 3 | |
2011 | 0 | 5.998.055 | 516.068 | 1 |
Total number of partners: 826
Partner loyalty:
Frequent Partner: (> 2 projects): 273
Rare Partner: 553
Frequent / Rare Partner Ratio: 0.49
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2014-02-01 | Treatment of late onset bacterial sepsis caused by vancomycin susceptible bacteria in neonates and infants aged under three months | NEOVANC | participant | 5.993.000 | 12 |
2013-12-01 | Clonidine for Sedation of Paediatric Patients in the Intensive Care Unit | CLOSED | participant | 5.997.405 | 10 |
2013-11-01 | Aggression subtyping for improved insight and treatment innovation in psychiatric disorders | AGGRESSOTYPE | participant | 6.000.000 | 23 |
2013-10-01 | "Development and Epilepsy - Strategies for Innovative Research to improve diagnosis, prevention and treatment in children with difficult to treat Epilepsy" | DESIRE | participant | 11.995.646 | 25 |
2013-03-01 | Model-Driven European Paediatric Digital Repository | MD PAEDIGREE | coordinator | 11.869.000 | 22 |
2011-10-01 | International study for treatment of childhood relapsed ALL 2010 with standard therapy, systematic integration of new agents, and establishment of standardized diagnostic and research | INTREALL | participant | 5.998.055 | 25 |